228 related articles for article (PubMed ID: 23734630)
1. Brain metastases from thyroid carcinoma: a retrospective study of 21 patients.
Henriques de Figueiredo B; Godbert Y; Soubeyran I; Carrat X; Lagarde P; Cazeau AL; Italiano A; Sargos P; Kantor G; Loiseau H; Bonichon F
Thyroid; 2014 Feb; 24(2):270-6. PubMed ID: 23734630
[TBL] [Abstract][Full Text] [Related]
2. Improved Survival After Multimodal Approach with
Wu D; Gomes Lima CJ; Moreau SL; Kulkarni K; Zeymo A; Burman KD; Wartofsky L; Van Nostrand D
Thyroid; 2019 Jul; 29(7):971-978. PubMed ID: 31017051
[No Abstract] [Full Text] [Related]
3. Brain Metastases From Differentiated Thyroid Carcinoma: A Retrospective Study of 22 Patients.
Wu T; Jiao Z; Li Y; Peng J; Yao F; Chen W; Yang A
Front Endocrinol (Lausanne); 2021; 12():730025. PubMed ID: 34603207
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic Radiosurgery for Differentiated Thyroid Cancer Brain Metastases: An International, Multicenter Study.
Bunevicius A; Fribance S; Pikis S; Lee JYK; Buch LY; Moran M; Yang AI; Bernstein K; Mathieu D; Perron R; Liscak R; Simonova G; Patel S; Trifiletti DM; Martínez Álvarez R; Martínez Moreno N; Lee CC; Yang HC; Strickland BA; Zada G; Chang EL; Kondziolka D; Sheehan J
Thyroid; 2021 Aug; 31(8):1244-1252. PubMed ID: 33978475
[No Abstract] [Full Text] [Related]
5. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
6. LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA AND BONE METASTASES.
Slook O; Levy S; Slutzky-Shraga I; Tsvetov G; Robenshtok E; Shimon I; Benbassat C; Hirsch D
Endocr Pract; 2019 May; 25(5):427-437. PubMed ID: 30657361
[No Abstract] [Full Text] [Related]
7. The Largest Known Survival Analysis of Patients with Brain Metastasis from Thyroid Cancer Based on Prognostic Groups.
Choi J; Kim JW; Keum YS; Lee IJ
PLoS One; 2016; 11(4):e0154739. PubMed ID: 27128487
[TBL] [Abstract][Full Text] [Related]
8. Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi-Institutional Experience.
Hughes RT; Masters AH; McTyre ER; Farris MK; Chung C; Page BR; Kleinberg LR; Hepel J; Contessa JN; Chiang V; Ruiz J; Watabe K; Su J; Fiveash JB; Braunstein S; Chao S; Attia A; Ayala-Peacock DN; Chan MD
Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1091-1098. PubMed ID: 30959122
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiosurgery for brain metastases from primary head and neck carcinomas: a retrospective analysis.
Patel RA; Bell JB; Kim T; Agulnik M; Chandler JP; Mittal BB; Kruser TJ
J Neurooncol; 2017 Aug; 134(1):197-203. PubMed ID: 28547589
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.
Marcus DM; Lowe M; Khan MK; Lawson DH; Crocker IR; Shelton JW; Melton A; Maynard N; Delman KA; Carlson GW; Rizzo M
Am J Clin Oncol; 2014 Dec; 37(6):580-4. PubMed ID: 23428955
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
13. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and prognostic factors in thyroid cancer patients with cranial metastases: A retrospective cohort study of 4,683 patients.
Hong YW; Lin JD; Yu MC; Hsu CC; Lin YS
Int J Surg; 2018 Jul; 55():182-187. PubMed ID: 29883619
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and follow-up of intracranial metastases from thyroid cancer.
Lee HS; Yoo H; Lee SH; Gwak HS; Shin SH
Acta Neurochir (Wien); 2015 Dec; 157(12):2185-94. PubMed ID: 26476828
[TBL] [Abstract][Full Text] [Related]
16. Is stereotactic radiosurgery a rational treatment option for brain metastases from small cell lung cancer? A retrospective analysis of 70 consecutive patients.
Yomo S; Hayashi M
BMC Cancer; 2015 Mar; 15():95. PubMed ID: 25879433
[TBL] [Abstract][Full Text] [Related]
17. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic radiosurgery in the management of brain metastases from primary thyroid cancers.
Bernad DM; Sperduto PW; Souhami L; Jensen AW; Roberge D
J Neurooncol; 2010 Jun; 98(2):249-52. PubMed ID: 20376550
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer.
Benbassat CA; Mechlis-Frish S; Hirsch D
World J Surg; 2006 Jun; 30(6):1088-95. PubMed ID: 16736341
[TBL] [Abstract][Full Text] [Related]
20. Is upfront stereotactic radiosurgery a rational treatment option for very elderly patients with brain metastases? A retrospective analysis of 106 consecutive patients age 80 years and older.
Yomo S; Hayashi M
BMC Cancer; 2016 Dec; 16(1):948. PubMed ID: 27978813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
